Bausch + Lomb Corporation (TSX:BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation. Offering a proprietary composition of lutein and zeaxanthin, OCUSorb has been clinically shown to provide superior absorption of these nutrients into the body as compared to the original PreserVision AREDS 2 mini soft gel formula.
Henry Schein Gears Up For Q3 Print; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts
Henry Schein, Inc. (NASDAQ: HSIC) is projected to release financial results for its third quarter, before the opening bell on Nov. 13, 2023.
